1. Home
  2. IGC vs XBP Comparison

IGC vs XBP Comparison

Compare IGC & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.28

Market Cap

30.0M

Sector

Health Care

ML Signal

HOLD

XBP

XBP Europe Holdings Inc.

N/A

Current Price

$2.50

Market Cap

29.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
IGC
XBP
Founded
2005
N/A
Country
United States
United States
Employees
N/A
10200
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
30.0M
29.3M
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
IGC
XBP
Price
$0.28
$2.50
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$5.25
$5.00
AVG Volume (30 Days)
565.0K
15.5K
Earning Date
03-19-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
59.09
N/A
EPS
N/A
N/A
Revenue
$1,271,000.00
N/A
Revenue This Year
N/A
$2.59
Revenue Next Year
$13.06
$5.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.41
52 Week High
$0.50
$8.55

Technical Indicators

Market Signals
Indicator
IGC
XBP
Relative Strength Index (RSI) 41.86 38.61
Support Level $0.28 $2.08
Resistance Level $0.31 $2.72
Average True Range (ATR) 0.01 0.22
MACD -0.00 0.02
Stochastic Oscillator 8.12 25.88

Price Performance

Historical Comparison
IGC
XBP

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About XBP XBP Europe Holdings Inc.

XBP Global Holdings Inc is a multinational technology and services company that drives intelligent workflows for organizations. Through its proprietary platforms, agentic AI-driven automation, and domain expertise across industries and the public and private sectors, the firm enables its clients to entrust their digital transformations and workflows. The segments of the company are Applied Workflow Automation and Technology. The Applied Workflow Automation segment generates maximum revenue and provides services powered by intelligent, AI-enabled workflows that generate outcomes for client's systems, while the Technology segment focuses on the sale of recurring and perpetual software licenses, software maintenance and professional services, as well as hardware solutions and maintenance.

Share on Social Networks: